Annual Long Term Debt
$44.98 M
-$8.05 M-15.18%
December 31, 2023
Summary
- As of February 7, 2025, DNLI annual long term debt is $44.98 million, with the most recent change of -$8.05 million (-15.18%) on December 31, 2023.
- During the last 3 years, DNLI annual long term debt has fallen by -$19.19 million (-29.91%).
- DNLI annual long term debt is now -34.68% below its all-time high of $68.86 million, reached on December 31, 2019.
Performance
DNLI Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$44.48 M
+$3.50 M+8.54%
September 30, 2024
Summary
- As of February 7, 2025, DNLI quarterly long term debt is $44.48 million, with the most recent change of +$3.50 million (+8.54%) on September 30, 2024.
- Over the past year, DNLI quarterly long term debt has increased by +$3.50 million (+8.54%).
- DNLI quarterly long term debt is now -37.71% below its all-time high of $71.41 million, reached on March 31, 2019.
Performance
DNLI Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
DNLI Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -15.2% | +8.5% |
3 y3 years | -29.9% | -16.1% |
5 y5 years | +100.0% | -16.1% |
DNLI Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -23.2% | at low | -24.0% | +8.5% |
5 y | 5-year | -34.7% | at low | -35.4% | +8.5% |
alltime | all time | -34.7% | -100.0% | -37.7% | -100.0% |
Denali Therapeutics Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $44.48 M(+8.5%) |
Jun 2024 | - | $40.98 M(-4.8%) |
Mar 2024 | - | $43.03 M(-4.3%) |
Dec 2023 | $44.98 M(-15.2%) | $44.98 M(-4.1%) |
Sep 2023 | - | $46.89 M(-3.8%) |
Jun 2023 | - | $48.75 M(-3.6%) |
Mar 2023 | - | $50.55 M(-4.7%) |
Dec 2022 | $53.03 M(-9.4%) | $53.03 M(-3.5%) |
Sep 2022 | - | $54.98 M(-1.0%) |
Jun 2022 | - | $55.52 M(-2.7%) |
Mar 2022 | - | $57.09 M(-2.5%) |
Dec 2021 | $58.55 M | $58.55 M(-2.4%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $59.99 M(-2.3%) |
Jun 2021 | - | $61.40 M(-2.4%) |
Mar 2021 | - | $62.92 M(-2.0%) |
Dec 2020 | $64.17 M(-6.8%) | $64.17 M(-1.9%) |
Sep 2020 | - | $65.41 M(-1.8%) |
Jun 2020 | - | $66.61 M(-1.7%) |
Mar 2020 | - | $67.79 M(-1.6%) |
Dec 2019 | $68.86 M(>+9900.0%) | $68.86 M(-1.5%) |
Sep 2019 | - | $69.92 M(-1.4%) |
Jun 2019 | - | $70.91 M(-0.7%) |
Mar 2019 | - | $71.41 M(>+9900.0%) |
Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Denali Therapeutics annual long term debt?
- What is the all time high annual long term debt for Denali Therapeutics?
- What is Denali Therapeutics annual long term debt year-on-year change?
- What is Denali Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Denali Therapeutics?
- What is Denali Therapeutics quarterly long term debt year-on-year change?
What is Denali Therapeutics annual long term debt?
The current annual long term debt of DNLI is $44.98 M
What is the all time high annual long term debt for Denali Therapeutics?
Denali Therapeutics all-time high annual long term debt is $68.86 M
What is Denali Therapeutics annual long term debt year-on-year change?
Over the past year, DNLI annual long term debt has changed by -$8.05 M (-15.18%)
What is Denali Therapeutics quarterly long term debt?
The current quarterly long term debt of DNLI is $44.48 M
What is the all time high quarterly long term debt for Denali Therapeutics?
Denali Therapeutics all-time high quarterly long term debt is $71.41 M
What is Denali Therapeutics quarterly long term debt year-on-year change?
Over the past year, DNLI quarterly long term debt has changed by +$3.50 M (+8.54%)